Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...

The FDA's approval was based on a study of 11,400 people, ages 12 and older, that compared the new low-dose vaccine with ...

The US FDA approved Moderna's next-generation COVID-19 vaccine, mNexspike, for adults 65+ and at-risk individuals aged 12-64.

They are getting a major change. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the vaccine’s ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this ...